Figshareopen access
Clinical events and healthcare costs of dapagliflozin in adults with cardiovascular-kidney-metabolic syndrome in Spain: a cost-offset analysis
medicine, pharmacology, sociology, marine biology, science policy, biological sciences not elsewhere classified, carbon dioxide footprint, cardiovascular-kidney-metabolic syndrome
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 307753
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.